Viewing Study NCT03202758


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-10 @ 3:27 PM
Study NCT ID: NCT03202758
Status: COMPLETED
Last Update Posted: 2023-02-10
First Post: 2017-06-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC
Sponsor: Centre Georges Francois Leclerc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Durvalumab View
None Tremelimumab View
None FOLFOX View
None metastatic colorectal cancer View